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Abstract
Structural eye disorders are increasingly recognised as having a genetic basis,
although current genetic testing is limited in its success. De novo missense variants in
WDR37 are a recently described cause of a multisystemic syndromic disorder featur-
ing ocular coloboma. This study characterises the phenotypic spectrum of this disor-
der and reports 2 de novo heterozygous variants (p.Thr115Ile, p.Ser119Tyr) in three
unrelated Caucasian individuals. All had a clinical phenotype consisting of bilateral iris
and retinal coloboma, developmental delay and additional, variable multisystem fea-
tures. The variants fall within a highly conserved region upstream of the WD-repeat
domains, within an apparent mutation cluster. Consistent with the literature, intellec-
tual disability, structural eye disorders, epilepsy, congenital heart disease, genitorenal
anomalies and dysmorphic facial features were observed. In addition, a broader
developmental profile is reported with a more specific musculoskeletal phenotype
described in association with the novel variant (p.Thr115Ile). We further expand the
phenotypic spectrum ofWDR37-related disorders to include those with milder devel-
opmental delay and strengthen the association of ocular coloboma and musculoskele-
tal features. We promote the inclusion of WDR37 on gene panels for intellectual
disability, epilepsy and structural eye disorders.
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1 | INTRODUCTION
Ocular coloboma has an estimated prevalence of 1 in 5000 live
births1,2 and may occur in isolation or form part of a multisystem syn-
dromic disorder.3 A significant proportion are likely to have a genetic
aetiology, although diagnosis is impeded by incomplete penetrance,
variable expressivity and genetic heterogeneity and only around 25%
of syndromic forms have a clinically recognisable disorder.4,5
Characterising the genetic aetiology of this diverse cohort is crucial to
reduce the diagnostic odyssey, inform reproductive counselling and
potentially alter management.
Recently, a total of seven unrelated individuals with four de novo
missense mutations in WDR37 were reported with a syndromic disor-
der featuring intellectual disability, epilepsy, craniofacial dysmorphism
and developmental eye anomalies.6,7 Here, we identify three individ-
uals with de novo missense variants inWDR37, who present with syn-
dromic features overlapping those reported. We further expand the
phenotypic spectrum to include those with milder developmental
delay and strengthen the association of WDR37 variants with ocular
coloboma and musculoskeletal features.
2 | MATERIALS AND METHODS
2.1 | Patients
Informed consent for Whole Genome Sequencing (WGS) was
obtained in accordance with approval from the HRA Committee East
of England—Cambridge South (REC Ref 14/EE/1112). Written,
informed consent was taken for publication from the patient's legal
guardians. Detailed phenotyping was undertaken by the recruiting
physicians and authors of this study (details available on request).
2.2 | Sequencing and segregation analysis
Trio (each parent and child) WGS was performed through the Geno-
mics England 100 000 Genomes Project (GE100KGP) as previously
described.8 From the undiagnosed dataset, rare, de novo variants
predicted to have a protein altering affect were reviewed in individ-
uals recruited with bilateral ocular coloboma. Alamut-v.2.6 (https://
www.interactive-biosoftware.com/alamut-visual/) was utilised in vari-
ant interpretation. Variants were confirmed by interrogation of the
individual paired-end reads using the Integrative Genomics
Viewer (IGV).9
3 | RESULTS
3.1 | Clinical phenotyping
The three individuals were born at term following uncomplicated
pregnancies. Family histories were uninformative and there was no
parental consanguinity. Ocular coloboma, low tone and delay in
reaching developmental milestones were noted in all three from
infancy and additional congenital anomalies prompted referral to oph-
thalmology and clinical genetics specialties. A range of investigations,
including neurometabolic screening, brain MRI, skin biopsy, chromo-
some microarray (CMA) and varied genetic testing were performed
and all were recruited to the GE100KGP. Clinical, neuroradiological
and ophthalmic images are presented in Figure 1.
Proband 1, a 3-year-old girl, was noted to have a left iris colo-
boma at 2 weeks of age. Bilateral retinal and optic disc coloboma
were later confirmed, alongside chorioretinal hyperpigmentation, left
amblyopia and myopia (Figure 1A,B). She developed tonic-clonic sei-
zures aged 11 months. Brain MRI showed the coloboma with exten-
sion into a left developmental cyst, mild corpus callosum and
cerebellar vermian dysplasia (Figure 1C,D,E). At review, she had mild
intellectual disability, long slender toes, brachycepahly and a unilat-
eral duplex kidney, although no reported cardiac, genital or skeletal
abnormalities. Growth parameters were tracking the 25th to 50th
centiles. CMA revealed a small de novo 17q12 copy number gain of
uncertain significance, involving eight genes. Smaller than the typical
17p12 microduplication region, this reduced penetrance
neurosusceptability locus is associated with wide ranging congenital
anomalies (although not typically coloboma) in one third of
individuals.10
Proband 2, a 15-year-old boy, had a perimembranous ventricular
septal defect and borderline Tetralogy of Fallot identified as a neonate
with a later identified mildly dilated aorta. He had a single febrile con-
vulsion aged 2 years, moderate learning disability, autistic spectrum
disorder and challenging feeding habits. Hypoplastic genitalia were
identified at birth, although became less apparent with age, and he
required operative repair of umbilical and left inguinal hernias and
bilateral orchidopexy. Renal ultrasound was normal. At last review, he
had bilateral iris and retinal coloboma, astigmatism, myopia and dis-
tinctive facial features (Figure 1F-I). He additionally had a broad neck,
mild thoracolumbar scoliosis, pectus excavatum, long, slender fingers,
joint hypermobility and ligament laxity. Growth parameters tracked
the 25th to 50th centiles.
Proband 3, a 14-year-old boy, developed medication responsive
seizures on day 10 of life. He discontinued antiepileptics aged
11 years and has remained seizure free with a normal EEG. His devel-
opment was globally delayed and at review he had a moderate intel-
lectual disability, four limb motor disorder, low central tone and an
anxiety-induced tremor. Neurodevelopmental assessment was sug-
gestive of a sensory processing disorder, reflected in his avoidant,
restrictive food intake. He had a structurally normal heart and no
known renal anomalies. A unilateral undescended testes and mild
umbilical hernia/everted umbilicus were noted at birth. He had bilat-
eral iris and retinal coloboma and astigmatism, brachycephaly and lam-
bdoid and metopic synostosis. Distinctive facial features are
documented in Figure 1K,L. He additionally had a broad neck, mild
thoracic scoliosis, long, slender fingers, joint hypermobility and liga-
ment laxity. Growth parameters tracked between the 9th and 25th
centiles.
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WGS revealed a candidate de novo missense variant in
WDR37, c.236C>A, p.(Ser119Tyr) (Figure 1M) in proband 1 follow-
ing negative gene panel analysis. Similar analysis of proband 2 and
3 identified, in both, a novel de novo missense variant in WDR37,
c.344C>T, p.(Thr115Ile) (Figure 1M). Both variants were absent
from gnomAD, affected a highly conserved amino acid and were
predicted to be damaging by in silico tools (SIFT, Polyphen2 and
MutationTaster). The variants collocated to the same region of
unknown function previously shown to harbour pathogenic variants,
between the coiled coil domain and the WD40 repeats
(Figure 1M).
Table 1 summarises the clinical features of our cases, alongside
the previously reported individuals. All individuals had eye abnormali-
ties with the majority (9/10) including ocular coloboma. Corneal/lens
anomalies and astigmatism, were also common. Non-ocular head and
neck features were frequently observed, with the most consistently
reported dysmorphisms including broad nasal bridge (9/9), ear anoma-
lies with low set and/or thickened helices (8/9), thin upper lip (7/8),
smooth philtrum (6/7), broad or webbed neck (6/8), wide mouth (4/5)
and prominent or arched eyebrows (4/7). Microcephaly was present
in five of nine reviewed.
Developmental delay and/or intellectual disability were universal
and typically in the moderate to severe spectrum. 70% to 80% addi-
tionally had a seizure disorder of varying severity and central hypoto-
nia. Of the individuals with MRI imaging, the most consistent features
were hypoplasia of the cerebellar vermis (8/8) and corpus callosum
(7/8). Musculoskeletal features from six individuals revealed five with
hypermobility, joint laxity and/or joint dislocations, five with digital
anomalies and four with scoliosis.
Challenging feeding was reported in 90% of cases and congenital
heart disease in 70%, principally septal defects or persistent ductus
arteriosus. 40% were reported to have structural renal anomalies and
all five males had genital anomalies, predominantly undescended tes-
tes and micropenis.
Our cohort's neurodevelopmental phenotype was less severe
overall, with the youngest showing only mild intellectual disability and
minor, although consistent MRI changes. Growth parameters in all
three were within the normal range. Whilst no consistent genotype to
F IGURE 1 Clinical and radiological features and WDR37 schematic. Proband 1 (A-E): Ocular images showing bilateral optic nerve coloboma
and inferior chorioretinal coloboma (A, B, arrows). Brain MRI images (12 months) highlighting mild corpus callosum dysgenesis (C, arrow) and very
mild superior cerebellar vermian dysplasia (C, star), hypoplastic olfactory nerves (D, right side encircled) and bilateral optic nerve coloboma with
left developmental cyst (E, arrow). Proband 2 (F-I): Clinical images aged 7 years (F) and 13 years (H, I) showing prominent, interrupted eyebrows,
broad nasal bridge, simple ears with thickened helices, wide mouth, thin upper lip, smooth philtrum and micrognathia. Proband 3 (J-L) aged
11 years showing prominent eyebrows, broad nasal bridge, thickened helices/lobes of the ears, wide mouth, thin upper lip, short philtrum,
prominent central incisors and micrognathia. Connective tissue disorder features were observed in Proband 2 and 3, including long slender fingers
(G, J). Simplified protein schematic (M-not to scale) highlights the colocation of previously reported variants in unrelated individuals (blue
triangles) and the three from this study (green triangles), between the coiled coil domain and seven WD40 repeats [Colour figure can be viewed
at wileyonlinelibrary.com]
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phenotype correlation was evident, the two probands in our study
with the same variant had a more specific musculoskeletal phenotype.
4 | DISCUSSION
The WDR37 protein belongs to the WD40 domain-containing protein
family, comprising around 1% of the human proteome.11 Their seven-
blade structures have roles in protein-protein interaction and molecu-
lar recognition in widespread biological processes, including transcrip-
tion regulation, signal transduction and histone modification.12 Over
60 WD40 proteins are classified as OMIM morbid, with dominant and
recessive inheritance recognised.
To date, there are 10 unrelated probands reported with six de
novo missense variants in WDR37 upstream of the WD repeats (Fig-
ure 1M). This region is highly conserved with complete sequence
homology (residues 107-137) from zebrafish to human. The probabil-
ity of loss of function intolerance (pLI) of WDR37 is 0.5713 (http://
gnomad.broadinstitute.org/) and 70 patients in Decipher (https://
decipher.sanger.ac.uk) have heterozygous deletions inclusive of
WDR37, suggesting a haploinsufficient model of disease is unlikely.
The effect of the missense variants is as yet unknown but they may
alter the protein conformation, potentially adding an additional pro-
peller blade.7 Of note, there is one individual in gnomAD with p.
Ser119Pro, a presumed benign variant at the same residue as three
affected individuals (p.Ser119Tyr and p.Ser119Phe), suggesting the
effect may be residue specific.
The International Mouse Phenotyping Consortium (IMPC), showed
murine Wdr37 knockout to have proportionately decreased overall
body weight, abnormal spinal curvature, decreased grip strength and
biochemical/haematological disturbance.14 Reis et al reported a detri-
mental effect on growth and viability of zebrafish with missense wdr37
variants, as opposed to the minimal effects observed with heterozy-
gous frameshift variants.6 Kanca et al recapitulated the results of the
IMPC in drosophila, with knockout flies showing significant bang sensi-
tivity (analogous to human seizures) and lower grip strength.7
Similar to other syndromic eye disorders, there is a broad pheno-
typic spectrum inWDR37-disease. This study supports the key pheno-
typic features previously reported withWDR37 variants, broadens the
clinical spectrum to include those with a milder neurodevelopmental
and radiological phenotype and highlights a more significant connec-
tive tissue like phenotype with joint hypermobility, hernias and aortic
root dilatation (in one) in association with p.Thr115Ile. Further work is
required to establish the full phenotypic range of individuals with
WDR37 variants.
Inclusion of WDR37 to relevant diagnostic panels will improve
diagnostic yield in the syndromic developmental eye disorder cohort,
essential in providing accurate reproductive risk to couples, reducing
unnecessary investigations and ensuring early renal and cardiac
assessment to look for associated systemic features. Given the broad
spectrum of clinical presentation, WDR37 variants should be
considered in patients presenting with multisystem syndromic disor-
ders, intellectual disability, epilepsy and anterior segment anomalies,
particularly ocular coloboma.
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